glp 1 news GLP-1 Prescriptions Quadruple Since 2021 Alongside Decline In Obesity Medicare is about to cover

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators

When facing supply shortages, patients should never switch to unapproved alternatives

These agents improve glycemic control, lower blood pressure, support weight reduction, and offer well-documented cardioprotective benefits

We were MANAGING her disease, Rothberg says

In some of the trials, we saw that individuals who had those variants were unable to lower their blood glucose levels as effectively after six months of treatment, said Anna Gloyn, DPhil, professor of pediatrics and of genetics, and one of the studys senior authors